pipette
ENEnglish

Effects of water quality, sanitation, handwashing and nutritional interventions on enteric pathogen seroconversion in rural Bangladesh: a cluster randomised trial

M. Rahman, P. Ante-Testard, R. W. Kihoro, H. Kanyi, H. Emisiko, H. Hu, E. Kamau, E. B. Goodhew, C. Coleman, S. Ali, M. Z. Rahman, A. K. Shoab, M. R. Miah, S. Ashraf, S. M. Parvez, M. M. Shakil, S. J. Bents, J. Colado, N. Walas, J. A. Grembi, R. C. Charles, E. T. Ryan, C. Munroe, R. L. Atmar, J. Benjamin-Chung, A. Ercumen, A. N. Mertens, A. Lin, P. J. Lammie, C. P. Stewart, J. M. Colford, S. P. Luby, S. M. Njenga, R. Haque, J. W. Priest, B. F. Arnold

PreprintUso en el mundo real

En palabras de los autores

Background: Improvements to water quality, sanitation, handwashing (WASH) and nutrition may prevent enteric pathogen infection during the first two years of life. Few randomised controlled trials have measured pathogen-specific effects of WASH and nutritional interventions. Methods: Within a 2x2 factorial cluster-randomized trial of WASH and nutritional interventions in Bangladesh, we tested dried blood spot specimens with multiplex assay for IgG responses to 12 enteric pathogens: Norovirus, Campylobacter, LT-producing enterotoxigenic E. coli (LT-ETEC), Shigella, non-typhoidal and typhoidal Salmonella enterica, Vibrio cholerae, Cryptosporidium, Giardia, Entamoeba histolytica, Taenia solium, and Strongyloides stercoralis. Primary analysis included children with IgG measurements at ~24 months, and secondary analysis assessed early effects in a sub-study at ~14 months. We estimated age-specific seroprevalence and marginal seroprevalence differences for WASH and nutrition effects. Trial is registered with ClinicalTrials.gov (NCT01590095). Findings: Across the four arms (450 clusters), 4817 samples were tested for IgG responses, 2453 samples at the primary endpoint. Seroprevalence increased with age, consistent with intense early-life transmission. For highest transmission pathogens, >94% of children had seroconverted to norovirus, LT-ETEC and Campylobacter by 12-18 months. WASH effects were modest and pathogen-specific but generally protective. At 24 months, children that received WASH interventions had less antibody against Shigella (-4.5%, 95% CI -7.6% to -1.5%), non-typhoidal S. enterica (-4.0%, 95% CI -6.5% to -1.5%), and Giardia (-3.4%, 95% CI -6.7% to -0.2%), although not after multiple-testing correction. Nutrition had limited effects on most enteric pathogens, but reduced non-typhoidal S. enterica at 14 months (-6.4%, 95% CI: -9.8% to -3.0%). Interpretation: Multiplex serology provided evidence that WASH may modestly reduce cumulative exposure to selected enteric pathogens, but household-level interventions were insufficient to substantially disrupt transmission in this high-exposure setting. Funding: National Institutes of Health (R01AI166671, R01AI106878, R01AI134814). The original WASH Benefits trial was funded by Gates Foundation (OPPGD759).

Resultado principalLimitación que admiten los autores

Apareció: lunes, 2 de noviembre. medRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.10.30.26366885